Seeing Is Believing
Currently out of the existing stock ratings of Adam Maeder, 181 are a BUY (76.05%), 52 are a HOLD (21.85%), 5 are a SELL (2.1%).
Analyst Adam Maeder works at PIPER SANDLER with a stock forecast success ratio of 55.49% fulfilled within 94.56 days on average.
Adam Maederās has documented 473 price targets and ratings displayed on 18 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NARI, Inari MedicalĀ at 01-May-2024.
Analyst best performing recommendations are on ZYXI (ZYNEX).
The best stock recommendation documented was for SILK (SILK ROAD MEDICAL) at 1/13/2021. The price target of $58 was fulfilled within 1 day with a profit of $2.98 (5.42%) receiving and performance score of 54.16.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
10
13
1 years 3 months 12 days ago
1/2 (50%)
$0.16 (1.63%)
70
Hold
10
10
1 years 4 months 1 days ago
3/4 (75%)
$0.12 (1.21%)
193
Hold
10
14
1 years 5 months 5 days ago
1/5 (20%)
$-0.13 (-1.28%)
13
Buy
9
$-1 (-10.00%)
13
2 years 1 days ago
1/3 (33.33%)
$3.44 (61.87%)
209
Buy
12
$2 (20.00%)
14
2 years 2 months 12 days ago
9/13 (69.23%)
$6.64 (123.88%)
124
Which stock is Adam Maeder is most bullish on?
Which stock is Adam Maeder is most reserved on?
What Year was the first public recommendation made by Adam Maeder?